Esophageal adenocarcinoma Trials in Boston, United States
Conditions / Esophageal adenocarcinoma / Boston, United States
Esophageal adenocarcinoma has been the subject of sustained clinical investigation across multiple research sites.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01196390 | Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer | COMPLETED | PHASE3 |
| NCT07090499 | A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT06324357 | Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread | RECRUITING | — |
| NCT04389632 | A Study of Sigvotatug Vedotin in Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT02872116 | Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer | COMPLETED | PHASE3 |
| NCT03809624 | Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer | TERMINATED | PHASE1 |
| NCT05252416 | (VELA) Study of BLU-222 in Advanced Solid Tumors | TERMINATED | PHASE1 |
| NCT06324357 | Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread | RECRUITING | — |
| NCT04900818 | Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors | RECRUITING | PHASE1 |
| NCT03604991 | Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery | SUSPENDED | PHASE2/PHASE3 |